SEGMENT AND GEOGRAPHIC INFORMATION - Net Sales and Profit by Reportable Segment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Segment Net Sales
Total Revenues	$ 380,834	$ 382,421	$ 1,167,881	$ 1,144,534
Segment Profit
Operating income	(8,150)	26,593	(7,216)	75,479
Amortization	(3,760)	(3,208)	(17,575)	(9,342)
Operating Segments
Segment Profit
Operating income	129,020	136,959	464,506	424,576
Corporate and other
Segment Profit
Operating income	(133,410)	(107,158)	(454,147)	(339,755)
Codman Specialty Surgical
Segment Net Sales
Total Revenues	270,782	268,205	828,977	787,371
Codman Specialty Surgical | Operating Segments
Segment Profit
Operating income	100,538	105,170	368,171	332,444
Tissue Technologies
Segment Net Sales
Total Revenues	110,052	114,216	338,904	357,163
Tissue Technologies | Operating Segments
Segment Profit
Operating income	$ 28,482	$ 31,789	$ 96,335	$ 92,132